Cargando…

First-in-human phase 0 study of (111)In-CHX-A”-DTPA trastuzumab for HER2 tumor imaging

INTRODUCTION: Tumors over-expressing the human epithelial receptor 2 (HER2) or exhibiting amplification or mutation of its proto-oncogene have a poorer prognosis. Using trastuzumab and/or other HER2 targeted therapies can increase overall survival in patients with HER2(+) tumors making it critical t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurdziel, KA, Mena, E, McKinney, Y, Wong, K, Adler, S, Sissung, T, Lee, J, Lipkowitz, S, Lindenberg, L, Turkbey, B, Kummar, S, Milenic, DE, Doroshow, JH, Figg, WD, Merino, MJ, Paik, CH, Brechbiel, MW, Choyke, PL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425962/ https://www.ncbi.nlm.nih.gov/pubmed/30906574 http://dx.doi.org/10.15761/JTS.1000269

Ejemplares similares

Preclinical Evaluation and Dosimetry of [(111)In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1)
por: Cicone, Francesco, et al.
Publicado: (2020)

Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial
por: Milenic, Diane E., et al.
Publicado: (2015)

Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and (212)Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model
por: Yong, Kwon Joong, et al.
Publicado: (2016)

Safety and biodistribution of (111)In-amatuximab in patients with mesothelin expressing cancers using Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT) imaging
por: Lindenberg, Liza, et al.
Publicado: (2015)

Gene expression profiling upon (212)Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model
por: Yong, Kwon J, et al.
Publicado: (2013)

The roles of the cation transporters CHX21 and CHX23 in the development of Arabidopsis thaliana
por: Evans, A. R., et al.
Publicado: (2012)

A new method for chlorhexidine (CHX) determination: CHX release after application of differently concentrated CHX-containing preparations on artificial fissures
por: Attin, Thomas, et al.
Publicado: (2007)

Synthesis, Radiolabelling and In Vitro Characterization of the Gallium-68-, Yttrium-90- and Lutetium-177-Labelled PSMA Ligand, CHX-A''-DTPA-DUPA-Pep
por: Baur, Benjamin, et al.
Publicado: (2014)

Pre-Clinical Assessment of (177)Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease
por: Ray, Geoffrey L., et al.
Publicado: (2011)

Straightforward thiol-mediated protein labelling with DTPA: Synthesis of a highly active (111)In-annexin A5-DTPA tracer
por: Kratz, Harald, et al.
Publicado: (2012)

Multimodal image-guided surgery of HER2-positive breast cancer using [(111)In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model
por: Deken, Marion M., et al.
Publicado: (2019)

Clinical Efficacy of 1% CHX Gluconate Gel and 0.12% CHX Solution: A Randomized Controlled Trial
por: Lee, Su-Young, et al.
Publicado: (2022)

Synthesis, Drug Release, and Antibacterial Properties of Novel Dendritic CHX-SrCl(2) and CHX-ZnCl(2) Particles
por: Sun, Rui, et al.
Publicado: (2021)

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
por: Brom, Maarten, et al.
Publicado: (2012)

The Role of MRI in Prostate Cancer Active Surveillance
por: Johnson, Linda M., et al.
Publicado: (2014)

(111)In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin
por: Cornelissen, Bart, et al.
Publicado: (2012)

Diagnostic Value of Radioisotope Cisternography Using (111)In-DTPA in a Patient with Rhinorrhea and Purulent Meningitis
por: Porubcin, Stefan, et al.
Publicado: (2022)

A Proteomic Analysis of Discolored Tooth Surfaces after the Use of 0.12% Chlorhexidine (CHX) Mouthwash and CHX Provided with an Anti-Discoloration System (ADS)
por: Bergamini, Stefania, et al.
Publicado: (2021)

Cycloheximide (CHX) Chase Assay to Examine Protein Half-life
por: Miao, Ying, et al.
Publicado: (2023)

Influence of tumour size on uptake of(111)In-DTPA-labelled pegylated liposomes in a human tumour xenograft model
por: Harrington, K J, et al.
Publicado: (2000)

Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted
por: Sissung, Tristan M., et al.
Publicado: (2022)

CHX and a Face Shield Cannot Prevent Contamination of Surgical Masks
por: Gund, Madline P., et al.
Publicado: (2022)

Pedunculopontine Chx10(+) neurons control global motor arrest in mice
por: Goñi-Erro, Haizea, et al.
Publicado: (2023)

Impact of α-Targeted Radiation Therapy on Gene Expression in a Pre-Clinical Model for Disseminated Peritoneal Disease when Combined with Paclitaxel
por: Yong, Kwon Joong, et al.
Publicado: (2014)

(212)Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint
por: Yong, K J, et al.
Publicado: (2013)

Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts
por: Yong, Kwon Joong, et al.
Publicado: (2016)

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers
por: Lochrin, Sarah E., et al.
Publicado: (2021)

Positron emission tomography (PET) in primary prostate cancer staging and risk assessment
por: Bednarova, Sandra, et al.
Publicado: (2017)

Biodistribution and pharmacokinetics of(111)In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies
por: Harrington, K J, et al.
Publicado: (2000)

Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
por: Wangberg, B., et al.
Publicado: (1996)

Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [(111)In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer
por: Chan, Conrad, et al.
Publicado: (2022)

HER1-Targeted (86)Y-Panitumumab Possesses Superior Targeting Characteristics than (86)Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts
por: Nayak, Tapan K., et al.
Publicado: (2011)

In Vitro and In Vivo Analysis of Indocyanine Green-Labeled Panitumumab for Optical Imaging—A Cautionary Tale
por: Zhou, Yang, et al.
Publicado: (2014)

Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
por: Milenic, Diane E., et al.
Publicado: (2017)

Antibacterial efficacy of Azadirachta indica, Mimusops elengi and 2% CHX on multispecies dentinal biofilm
por: Mistry, Kunjal S., et al.
Publicado: (2015)

Author Correction: Pedunculopontine Chx10(+) neurons control global motor arrest in mice
por: Goñi-Erro, Haizea, et al.
Publicado: (2023)

CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer
por: Lee, Jung-Min, et al.
Publicado: (2015)

Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer
por: Lee, Jung-Min, et al.
Publicado: (2017)

Atypical Response Regulator ChxR from Chlamydia trachomatis Is Structurally Poised for DNA Binding
por: Barta, Michael L., et al.
Publicado: (2014)

Intrinsic brainstem circuits comprised of Chx10-expressing neurons contribute to reticulospinal output in mice
por: Chopek, Jeremy W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6a59589ilcnlm42fth015mlonf